Penner Louis A, Dovidio John F, Gonzalez Richard, Albrecht Terrance L, Chapman Robert, Foster Tanina, Harper Felicity W K, Hagiwara Nao, Hamel Lauren M, Shields Anthony F, Gadgeel Shirish, Simon Michael S, Griggs Jennifer J, Eggly Susan
Louis A. Penner, Terrance L. Albrecht, Tanina Foster, Felicity W.K. Harper, Lauren M. Hamel, Anthony F. Shields, Shirish Gadgeel, Michael S. Simon, and Susan Eggly, Wayne State University; Robert Chapman, Henry Ford Health Care System, Detroit; Richard Gonzalez and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI; John F. Dovidio, Yale University, New Haven, CT; and Nao Hagiwara, Virginia Commonwealth University, Richmond, VA.
J Clin Oncol. 2016 Aug 20;34(24):2874-80. doi: 10.1200/JCO.2015.66.3658. Epub 2016 Jun 20.
Health providers' implicit racial bias negatively affects communication and patient reactions to many medical interactions. However, its effects on racially discordant oncology interactions are largely unknown. Thus, we examined whether oncologist implicit racial bias has similar effects in oncology interactions. We further investigated whether oncologist implicit bias negatively affects patients' perceptions of recommended treatments (i.e., degree of confidence, expected difficulty). We predicted oncologist implicit bias would negatively affect communication, patient reactions to interactions, and, indirectly, patient perceptions of recommended treatments.
Participants were 18 non-black medical oncologists and 112 black patients. Oncologists completed an implicit racial bias measure several weeks before video-recorded treatment discussions with new patients. Observers rated oncologist communication and recorded interaction length of time and amount of time oncologists and patients spoke. Following interactions, patients answered questions about oncologists' patient-centeredness and difficulty remembering contents of the interaction, distress, trust, and treatment perceptions.
As predicted, oncologists higher in implicit racial bias had shorter interactions, and patients and observers rated these oncologists' communication as less patient-centered and supportive. Higher implicit bias also was associated with more patient difficulty remembering contents of the interaction. In addition, oncologist implicit bias indirectly predicted less patient confidence in recommended treatments, and greater perceived difficulty completing them, through its impact on oncologists' communication (as rated by both patients and observers).
Oncologist implicit racial bias is negatively associated with oncologist communication, patients' reactions to racially discordant oncology interactions, and patient perceptions of recommended treatments. These perceptions could subsequently directly affect patient-treatment decisions. Thus, implicit racial bias is a likely source of racial treatment disparities and must be addressed in oncology training and practice.
医疗服务提供者的隐性种族偏见会对沟通以及患者对许多医疗互动的反应产生负面影响。然而,其对种族不和谐的肿瘤学互动的影响在很大程度上尚不清楚。因此,我们研究了肿瘤学家的隐性种族偏见在肿瘤学互动中是否有类似影响。我们进一步调查了肿瘤学家的隐性偏见是否会对患者对推荐治疗的看法(即信心程度、预期难度)产生负面影响。我们预测肿瘤学家的隐性偏见会对沟通、患者对互动的反应产生负面影响,并间接影响患者对推荐治疗的看法。
参与者包括18名非黑人肿瘤内科医生和112名黑人患者。肿瘤内科医生在与新患者进行视频记录的治疗讨论前几周完成一项隐性种族偏见测量。观察者对肿瘤内科医生的沟通进行评分,并记录互动时长以及肿瘤内科医生和患者说话的时间量。互动结束后,患者回答有关肿瘤内科医生以患者为中心的程度、难以记住互动内容、痛苦、信任以及治疗看法等问题。
正如预测的那样,隐性种族偏见较高的肿瘤内科医生互动时间较短,患者和观察者将这些肿瘤内科医生的沟通评价为以患者为中心和支持性较差。较高的隐性偏见还与患者更难记住互动内容有关。此外,肿瘤内科医生的隐性偏见通过其对肿瘤内科医生沟通的影响(患者和观察者的评分)间接预测患者对推荐治疗的信心较低,以及认为完成这些治疗的难度更大。
肿瘤内科医生的隐性种族偏见与肿瘤内科医生的沟通、患者对种族不和谐的肿瘤学互动的反应以及患者对推荐治疗看法呈负相关。这些看法随后可能直接影响患者的治疗决策。因此,隐性种族偏见很可能是种族治疗差异的一个来源,必须在肿瘤学培训和实践中加以解决。